Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

Current HIV/AIDS Reports
Katherine M RichJudith Feinberg

Abstract

To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care (N = 3), HIV specialty care (N = 5), opioid treatment programs (N = 6), transitional clinics (N = 2), and community-based harm reduction programs (N = 1), as well as two emerging models. Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the "War on Drugs," and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial.

References

May 1, 1994·AIDS·E H Kaplan, R Heimer
Jun 15, 1994·JAMA : the Journal of the American Medical Association·R Heimer, M Lopes
Jan 12, 1994·JAMA : the Journal of the American Medical Association·J K WattersJ Lorvick
Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra A SpringerFrederick L Altice
May 25, 2006·Journal of the American Academy of Nurse Practitioners·Daisha J CipherPatricia Guerra
Aug 11, 2007·The International Journal on Drug Policy·Laurie SyllaFrederick L Altice
May 17, 2008·International Journal of STD & AIDS·Megan S C LimCampbell K Aitken
Aug 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Duncan Smith-Rohrberg MaruFrederick L Altice
Dec 18, 2008·Journal of General Internal Medicine·Declan T BarryDavid A Fiellin
Jan 13, 2009·American Journal of Preventive Medicine·Brianna S FjeldsoeYvette D Miller
Nov 1, 2007·Current Opinion in HIV and AIDS·Marija Zeremski, Andrew H Talal
Jan 1, 2008·Journal of Diabetes Science and Technology·David L Katz, Bjorn Nordwall
Jul 8, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sanjeev AroraWesley Pak
Jul 24, 2010·Lancet·Steffanie A StrathdeeCatherine A Hankins
Oct 19, 2010·HIV Therapy·Sarah E Wakeman, Josiah D Rich
Mar 1, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·James E EganUNKNOWN BHIVES Collaborative
Mar 1, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Linda WeissUNKNOWN BHIVES Collaborative
Jun 3, 2011·The New England Journal of Medicine·Sanjeev AroraClifford Qualls
Jul 15, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Xu WangWen-Zhe Ho
Nov 11, 2011·International Journal of Environmental Research and Public Health·Thomas F Kresina, Robert Lubran
Jun 12, 2012·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Stephen E LankenauMeghan Treese
Aug 10, 2012·Journal of Addictive Diseases·Gavin Bart
Nov 20, 2012·AIDS and Behavior·Amy L AlthoffFrederick L Altice
Aug 27, 2013·The International Journal on Drug Policy·Georgina J MacArthurSharon J Hutchinson
Nov 19, 2013·The International Journal on Drug Policy·Sarah G MarsDaniel Ciccarone
Feb 11, 2014·Journal of Health Care for the Poor and Underserved·Aaron D FoxChinazo O Cunningham
Mar 4, 2014·Public Health Reports·Aiden K VaranAnne C Spaulding
Apr 3, 2014·Current HIV/AIDS Reports·Sten H Vermund
May 31, 2014·Journal of Addiction Medicine·Angela K ClarkErin L Winstanley
Aug 19, 2014·Journal of Health Care for the Poor and Underserved·Aaron D FoxChinazo O Cunningham
Jan 8, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David S MetzgerUNKNOWN HPTN 058 Protocol Team

❮ Previous
Next ❯

Citations

Nov 15, 2018·Addiction Science & Clinical Practice·Matthew A MicletteZachary F Meisel
Aug 10, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Oluwaseun Falade-NwuliaShruti H Mehta
Mar 3, 2019·International Journal of Environmental Research and Public Health·Saria HassanBarrot H Lambdin
Jul 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chih-Yuan WangYu-Tse Wu
Jan 11, 2020·Nature Reviews. Disease Primers·John StrangSharon L Walsh
Jul 1, 2019·Infectious Disease Clinics of North America·Christopher M Bositis, Joshua St Louis
Feb 12, 2021·Journal of General Internal Medicine·Judith I TsuiKatharine A Bradley
May 21, 2021·BMJ : British Medical Journal·Megan BureshDarius Rastegar
Jun 3, 2021·International Journal of Environmental Research and Public Health·Morgane Guillou-LandreatCaroline Victorri-Vigneau
Aug 5, 2021·The International Journal on Drug Policy·Jesse L YedinakBrandon D L Marshall

❮ Previous
Next ❯

Software Mentioned

mHealth
CHESS
BHIVES
ECHO
Scopus
Ovid Medline

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved